CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
5 Stocks in the Limelight After Recent Broker Rating Upgrade
by Maharathi Basu
Broker opinion acts as a valuable guide for investors while deciding their course of action on a particular stock.
Top Ranked Momentum Stocks to Buy for September 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 16th
Is Deep Value ETF (DVP) a Strong ETF Right Now?
by Sweta Killa
Smart Beta ETF report for DVP
CVS Health (CVS) Up 6.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is CVS Health (CVS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HealthEquity Acquires WageWorks, To Make Notable Investments
by Zacks Equity Research
HealthEquity (HQY) expects to complete its $80-100 million investment program within 24-36 months from now.
Zacks.com featured highlights include: CVS Health, Asbury Automotive, Anixter International, Cincinnati Bell and AmerisourceBergen
by Zacks Equity Research
Zacks.com featured highlights include: CVS Health, Asbury Automotive, Anixter International, Cincinnati Bell and AmerisourceBergen
Recent Broker Rating Upgrades Add Luster to These 5 Stocks
by Maharathi Basu
Since brokers follow stocks in their coverage minutely, their advice is invaluable for individual investors as the latter aim for lucrative returns.
Top Ranked Momentum Stocks to Buy for August 29th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 29th
Is Deep Value ETF (DVP) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVP
CVS Health Banks on Health Care Benefit Prospects Amid Woes
by Zacks Equity Research
CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition is gaining a strong momentum.
Zacks.com featured highlights include: Diebold Nixdorf, CVS Health, AmerisourceBergen, AutoNation and Clearwater Paper
by Zacks Equity Research
Zacks.com featured highlights include: Diebold Nixdorf, CVS Health, AmerisourceBergen, AutoNation and Clearwater Paper
5 Stocks That Brokers Currently Love
by Maharathi Basu
Investors aim to generate maximum returns from their portfolio. Therefore, it is in their best interests to pay heed to well-researched information accumulated by brokers.
Should Value Investors Buy CVS Health (CVS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CVS Stock Jumps 7% After Strong Earnings: What's Next for the Pharmacy Giant?
by Zachary Stutler
CVS (CVS) reported its Q2 earnings results Wednesday morning and beat our estimates by 11%.
Company News for Aug 8, 2019
by Zacks Equity Research
Companies in the news are: DIS, CVS, CPRI and ODP
CVS Health (CVS) Beats on Q2 Earnings, Raises '19 Guidance
by Zacks Equity Research
CVS Health's (CVS) second-quarter top-line growth in Pharmacy Services segment is backed by an uptick in specialty services.
U.S. Stock Index Futures Move Lower
by Zacks Equity Research
U.S. stock index futures moved lower
Stock Futures Fall as Trade Worries Spook Wall Street
by Zacks Equity Research
U.S. stock index futures moved lower ahead of trading on Wednesday after rising trade tensions led to concerns that a global economic slowdown was likely.
CVS Health (CVS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 11.18% and 1.31%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Outlook for Health Insurance Industry Looks Sanguine
by Sapna Bagaria
Consolidation, increasing senior population, technological advancements and development of supplementary healthcare businesses poise the health insurance industry for secular growth.
Buy CVS Health (CVS) Ahead of Q2 Earnings?
by Christopher Vargas
CVS Health (CVS) will be reporting their second quarter before the opening bell on Wednesday.
Can Pharmacy Services Drive CVS Health's (CVS) Q2 Earnings?
by Zacks Equity Research
Akin to the previous quarters, net new business and the steady uptake of Maintenance Choice programs are likely to bolster CVS Health's (CVS) PBM business in Q2.
Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?
by Zacks Equity Research
Within the Health Care Benefits segment, CVS Health (CVS) expects the government programs to go from strength to strength on the back of Medicare growth and major Medicaid wins.
3 Retail Stocks Likely to Stand Tall This Earnings Season
by Zacks Equity Research
Retailers are making prudent investments to strengthen digital ecosystem and bolster shipping and delivery capabilities. While these drive sales, they entail high costs. Margins remain one of the key areas to watch.